Description
Orlistat research compound
Orlistat is a reversible inhibitor of gastric and pancreatic lipases, derived from lipstatin.
Product details
| Compound | Orlistat |
|---|---|
| Class | Gastrointestinal lipase inhibitor |
| Form | Powder; Tablets |
| Strength | 5g; 80mg per tablet/90ct/7.2g |
| Labelling | Compound name and strength on every container |
Select your format and strength from the options above.
What Orlistat research has examined
- Lipase inhibition.
- Fatty-acid synthase inhibition: oncology research.
- Lipid absorption research.
Research interest does not establish a proven effect in humans.
Regulatory status
Licensed medicines containing this active ingredient are prescription-only products made by authorised manufacturers. The material sold here is a research chemical, not a licensed medicine, and is not approved for any use in humans.
Storage and handling
Keep the container tightly closed, at room temperature or cooler, away from moisture and light.
Related research products
Kanna 200:1 Full Spectrum Mesembrine Alkaloid · Flammulina Velutipes 30% · Berberine HCL · All botanical powders
References
For laboratory research use only. Not for human or animal consumption. Not intended to diagnose, treat, cure or prevent any disease.
Reviews
There are no reviews yet.